Cytokinetics, Inc. (CYTK)
63.36
+1.02
(+1.64%)
USD |
NASDAQ |
Feb 09, 16:00
63.37
+0.01
(+0.02%)
After-Hours: 20:00
Cytokinetics Market Cap : 7.747B for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Molina Healthcare, Inc. | 6.555B |
| Bristol Myers Squibb Co. | 123.71B |
| Fortrea Holdings, Inc. | 1.380B |
| Lifecore Biomedical, Inc. | 279.69M |
| Regeneron Pharmaceuticals, Inc. | 82.49B |
Market Cap Related Metrics
| PS Ratio | 86.46 |
| PEG Ratio | -0.588 |
| Price | 63.36 |
| Earnings Yield | -9.96% |
| PEGY Ratio | -0.588 |